Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITI-1284 in Psychosis Associated With Alzheimer's Disease
NCT06540833Phase 2Recruiting
- Sponsor
- Intra-Cellular Therapies
- Start
- Aug 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of deulumateperone in psychosis, sponsored by Intra-Cellular Therapies. Started Aug 2024; status: recruiting.
02
Drugs
deulumateperone
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT06540833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06540833.